In this dynamic environment, identifying small-cap stocks like Anbio Biotechnology that possess strong growth potential and innovative capabilities can offer intriguing opportunities for investors ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. IVD products are designed to detect a wide range of biomarkers ...

How did Anbio Biotechnology Class A Ordinary Shares do last quarter? What was its Total Revenue and Cost of Revenue? A company's Total Revenue reveals how much money it generates before any expenses ...

Who are the major shareholders selling Anbio Biotechnology Class A Ordinary Shares stock? N/A, in the last quarter, reduced its stake in NNNN by N/A restricting it's holding to - shares of worth ...

Over the last 7 days, the United States market has risen by 2.1%, contributing to a year-long climb of 8.1%, with earnings forecasted to grow by 14% annually. In this dynamic environment, discovering ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

The Cambridge, Massachusetts-based biotech is closing “following careful consideration of potential paths forward and strategic factors,” HC CEO and cofounder Leslie Williams said in an ...

With the global biotechnology industry projected to grow at almost 14% annually through 2030, organizations are embracing innovative strategies to drive growth and differentiate themselves.

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other ...